Andra Ap Fonden Jazz Pharmaceuticals PLC Transaction History

Andra Ap Fonden

$6.64 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$114.26 - $136.0 $1.35 Million - $1.6 Million	11,800 Added 20.74%	68,700 $8.45 Million
Q3 2023 Nov 09, 2023	SELL	$122.0 - $145.31 $719,800 - $857,329	-5,900 Reduced 9.39%	56,900 $7.37 Million
Q2 2023 Aug 09, 2023	BUY	$122.5 - $147.16 $3.34 Million - $4.02 Million	27,300 Added 76.9%	62,800 $7.79 Million
Q1 2023 May 12, 2023	BUY	$133.98 - $160.47 $1.06 Million - $1.27 Million	7,900 Added 28.62%	35,500 $5.19 Million
Q4 2022 Feb 13, 2023	BUY	$129.72 - $159.85 $1.32 Million - $1.63 Million	10,200 Added 58.62%	27,600 $4.4 Million
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $1.33 Million - $1.69 Million	10,500 Added 152.17%	17,400 $2.32 Million
Q2 2022 Aug 15, 2022	SELL	$141.59 - $168.66 $2.35 Million - $2.8 Million	-16,600 Reduced 70.64%	6,900 $1.08 Million
Q4 2021 Feb 15, 2022	SELL	$119.87 - $145.67 $2.24 Million - $2.72 Million	-18,700 Reduced 44.31%	23,500 $2.99 Million
Q3 2021 Nov 12, 2021	SELL	$128.64 - $184.79 $4.57 Million - $6.56 Million	-35,500 Reduced 45.69%	42,200 $5.5 Million
Q2 2021 Aug 16, 2021	SELL	$160.2 - $186.42 $1.73 Million - $2.01 Million	-10,800 Reduced 12.2%	77,700 $13.8 Million
Q1 2021 May 17, 2021	BUY	$150.19 - $173.5 $660,836 - $763,400	4,400 Added 5.23%	88,500 $14.5 Million
Q4 2020 Feb 12, 2021	BUY	$140.71 - $165.05 $4.31 Million - $5.05 Million	30,600 Added 57.2%	84,100 $13.9 Million
Q3 2020 Nov 12, 2020	SELL	$105.46 - $144.13 $52,730 - $72,065	-500 Reduced 0.93%	53,500 $7.63 Million
Q2 2020 Aug 06, 2020	BUY	$95.68 - $121.88 $889,824 - $1.13 Million	9,300 Added 20.81%	54,000 $5.96 Million
Q1 2020 May 13, 2020	BUY	$87.74 - $152.74 $140,384 - $244,384	1,600 Added 3.71%	44,700 $4.46 Million
Q4 2019 Feb 10, 2020	BUY	$117.65 - $153.73 $870,610 - $1.14 Million	7,400 Added 20.73%	43,100 $6.43 Million
Q3 2019 Nov 19, 2019	SELL	$125.18 - $143.24 $363,022 - $415,396	-2,900 Reduced 7.51%	35,700 $4.58 Million
Q2 2019 Aug 15, 2019	SELL	$125.55 - $144.48 $652,860 - $751,296	-5,200 Reduced 11.87%	38,600 $5.5 Million
Q1 2019 May 14, 2019	BUY	$121.81 - $142.95 $803,946 - $943,469	6,600 Added 17.74%	43,800 $6.26 Million
Q3 2018 Oct 16, 2018	BUY	$161.01 - $180.57 $80,505 - $90,285	500 Added 1.36%	37,200 $6.25 Million
Q2 2018 Aug 17, 2018	SELL	$146.33 - $183.18 $482,889 - $604,494	-3,300 Reduced 8.25%	36,700 $6.32 Million
Q1 2018 Apr 10, 2018	BUY	$135.59 - $157.16 $3.81 Million - $4.42 Million	28,100 Added 236.13%	40,000 $6.04 Million
Q4 2017 Feb 14, 2018	BUY	$131.06 - $150.39 $484,922 - $556,443	3,700 Added 45.12%	11,900 $1.6 Million
Q3 2017 Oct 31, 2017	BUY	$142.62 - $155.6 $1.17 Million - $1.28 Million	8,200	8,200 $1.2 Million

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.

Account